Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2015

01-05-2015 | Colorectal Cancer

Escalation of Socioeconomic Disparities Among Patients with Colorectal Cancer Receiving Advanced Surgical Treatment

Authors: Parissa Tabrizian, MD, Jessica Overbey, MS, Gonzalo Carrasco-Avino, MD, Emilia Bagiella, PhD, Daniel M. Labow, MD, FACS, Umut Sarpel, MD, FACS

Published in: Annals of Surgical Oncology | Issue 5/2015

Login to get access

Abstract

Background

As tumor burden increases in colorectal cancer, treatment complexity progresses from colectomy to hepatectomy and lastly to cytoreductive surgery with heated intraperitoneal chemotherapy (CRS-HIPEC). The aim of this study was to evaluate whether disparities exist in the access to progressively more complex surgical treatment options.

Methods

Patients undergoing surgery for colorectal cancer were grouped by treatment type: group 1 (n = 224) underwent colectomy for nonmetastatic disease, group 2 (n = 112) underwent hepatectomy for liver metastasis, and group 3 (n = 112) underwent CRS-HIPEC for carcinomatosis.

Results

Whites were predominant in the HIPEC group (71.4 %) compared to the hepatectomy (67.9 %) and colectomy (57.6 %) groups (p = 0.025). The majority of the privately insured patients were in the HIPEC group (70.5 %) compared to the hepatectomy (56.2 %) and colectomy (30.4 %) groups (p < 0.0001). Distance traveled to the hospital was farthest on average in the HIPEC group (104.6 ± 258.3 km) compared to the hepatectomy (29.0 ± 28.0 km) or colectomy (26.4  ± 66.2 km) group (p < 0.0001). Mean household income also varied between the three groups, with HIPEC patients earning $56,957 (±24,124), hepatectomy patients earning $56,999 (±28,588), and colectomy patients earning ($51,518 ± 24,201) (p = 0.0503) on average per year. The HIPEC cohort contained a higher proportion of English speakers (90.2 %) than the other groups (hepatectomy 87.9 %, colectomy 85.3 %); however, this difference was not statistically significant (p = 0.43).

Conclusions

CRS-HIPEC is not accessed equally across all socioeconomic groups. Patients undergoing HIPEC were most often white, English speaking, and privately insured; had a higher mean income; and had traveled the greatest distances on average to access surgical care.
Literature
1.
go back to reference Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–766.CrossRefPubMedCentralPubMed Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–766.CrossRefPubMedCentralPubMed
2.
go back to reference Sarpel U, Bonavia AS, Grucela A, et al. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol. 2009;16:379–384.CrossRefPubMed Sarpel U, Bonavia AS, Grucela A, et al. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol. 2009;16:379–384.CrossRefPubMed
3.
go back to reference Tabrizian P, Shrager B, Jibara G, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. 2014;18:1024–1031.CrossRefPubMed Tabrizian P, Shrager B, Jibara G, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. 2014;18:1024–1031.CrossRefPubMed
4.
go back to reference Verwaal VJ, Bruin S, Boot H, et al. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426e32. Verwaal VJ, Bruin S, Boot H, et al. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426e32.
6.
go back to reference Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA. 2006;296:1973–1980.CrossRefPubMed Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA. 2006;296:1973–1980.CrossRefPubMed
7.
go back to reference Epstein AJ, Gray BH, Schlesinger M. Racial and ethnic differences in the use of high-volume hospitals and surgeons. Arch Surg. 2010;145:179–186.CrossRefPubMed Epstein AJ, Gray BH, Schlesinger M. Racial and ethnic differences in the use of high-volume hospitals and surgeons. Arch Surg. 2010;145:179–186.CrossRefPubMed
8.
go back to reference Chang DC, Zhang Y, Mukherjee D, et al. Variations in referral patterns to high-volume centers for pancreatic cancer. J Am Coll Surg. 2009;209:720–726.CrossRefPubMedCentralPubMed Chang DC, Zhang Y, Mukherjee D, et al. Variations in referral patterns to high-volume centers for pancreatic cancer. J Am Coll Surg. 2009;209:720–726.CrossRefPubMedCentralPubMed
9.
go back to reference Sarpel U, Melis M, Newman E, et al. The development of a peritoneal surface malignancy program: a tale of three hospitals. J Cancer Educ. 2012;27:670–675.CrossRefPubMed Sarpel U, Melis M, Newman E, et al. The development of a peritoneal surface malignancy program: a tale of three hospitals. J Cancer Educ. 2012;27:670–675.CrossRefPubMed
10.
go back to reference Chen J, Rathore SS, Radford MJ, et al. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med. 2001;344:1443–1449.CrossRefPubMed Chen J, Rathore SS, Radford MJ, et al. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med. 2001;344:1443–1449.CrossRefPubMed
11.
go back to reference Spiegle G, Schmocker S, Huang H, et al. Physicians’ awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis. Can J Surg. 2013;56:237–42.CrossRefPubMedCentralPubMed Spiegle G, Schmocker S, Huang H, et al. Physicians’ awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis. Can J Surg. 2013;56:237–42.CrossRefPubMedCentralPubMed
12.
go back to reference Huang LC, Ma Y, Ngo JV, et al. What factors influence minority use of National Cancer Institute–designated cancer centers? Cancer. 2014;120:399–407.CrossRefPubMedCentralPubMed Huang LC, Ma Y, Ngo JV, et al. What factors influence minority use of National Cancer Institute–designated cancer centers? Cancer. 2014;120:399–407.CrossRefPubMedCentralPubMed
13.
go back to reference Massarweh NN, Chiang YJ, Xing Y, et al. Association between travel distance and metastatic disease at diagnosis among patients with colon cancer. J Clin Oncol. 2014;32:942–948.CrossRefPubMedCentralPubMed Massarweh NN, Chiang YJ, Xing Y, et al. Association between travel distance and metastatic disease at diagnosis among patients with colon cancer. J Clin Oncol. 2014;32:942–948.CrossRefPubMedCentralPubMed
Metadata
Title
Escalation of Socioeconomic Disparities Among Patients with Colorectal Cancer Receiving Advanced Surgical Treatment
Authors
Parissa Tabrizian, MD
Jessica Overbey, MS
Gonzalo Carrasco-Avino, MD
Emilia Bagiella, PhD
Daniel M. Labow, MD, FACS
Umut Sarpel, MD, FACS
Publication date
01-05-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 5/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4220-6

Other articles of this Issue 5/2015

Annals of Surgical Oncology 5/2015 Go to the issue